Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel

Cancer Research
Ayana SawaiDavid B Solit

Abstract

Mutations in the kinase domain of the epidermal growth factor receptor (EGFR) are found in a subset of patients with lung cancer and correlate with response to EGFR tyrosine kinase inhibitors (TKI). Resistance to these agents invariably develops, and current treatment strategies have limited efficacy in this setting. Hsp90 inhibitors, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), induce the degradation of EGFR and other Hsp90 interacting proteins and may thus have utility in tumors dependent upon sensitive Hsp90 clients. We find that the EGFR mutations found most commonly in patients with lung adenocarcinoma who respond to EGFR TKIs are potently degraded by 17-AAG. Although the expression of wild-type EGFR was also down-regulated by 17-AAG, its degradation required higher concentrations of drug and a longer duration of drug exposure. In animal models, a single dose of 17-AAG was sufficient to induce degradation of mutant EGFR and inhibit downstream signaling. 17-AAG treatment, at its maximal tolerated dose, caused a significant delay in H3255 (L858R EGFR) xenograft growth but was less effective than the EGFR TKI gefitinib. 17-AAG alone delayed, but did not completely inhibit, the growth of H1650 and H1975 xenografts,...Continue Reading

References

Jul 14, 1995·The Journal of Biological Chemistry·L Sepp-LorenzinoN Rosen
Oct 27, 1999·The Journal of Thoracic and Cardiovascular Surgery·D M NguyenD S Schrump
Jun 8, 2002·The Journal of Biological Chemistry·Jennifer S IsaacsLeonard M Neckers
Jun 26, 2004·Chemistry & Biology·Maria VilenchikGabriela Chiosis
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David B SolitFrank M Sirotnak
Sep 29, 2005·PLoS Medicine·Heidi GreulichMatthew Meyerson
Nov 12, 2005·The New England Journal of Medicine·Ingo K MellinghoffPaul S Mischel
Dec 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·O M GrbovicN Rosen
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory J RielyVincent A Miller
Jul 18, 2006·Current Topics in Medicinal Chemistry·David B Solit, Neal Rosen
Feb 24, 2007·Nature Reviews. Cancer·Sreenath V SharmaDaniel A Haber
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shanu ModiClifford A Hudis

❮ Previous
Next ❯

Citations

Feb 22, 2008·Histochemistry and Cell Biology·Kirstine RoepstorffBo van Deurs
Apr 19, 2011·Seminars in Respiratory and Critical Care Medicine·Ping Yang
Mar 28, 2012·The Journal of Experimental Medicine·Ninel AzoiteiClaudia Scholl
Sep 26, 2009·Antioxidants & Redox Signaling·Matteo LandriscinaFranca Esposito
Jan 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas Bachleitner-HofmannMartin R Weiser
Jul 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geoffrey R OxnardWilliam Pao
Jan 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Len Neckers, Paul Workman
Sep 21, 2010·The Journal of Clinical Investigation·Sachie MarubayashiRoss L Levine
Jun 17, 2010·PloS One·Ian J Restall, Ian A J Lorimer
Mar 26, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xing-Xing FanElaine Lai-Han Leung
May 18, 2011·Nucleic Acids Research·H Hans SalamancaJohn T Lis
Mar 4, 2014·Expert Opinion on Pharmacotherapy·Eilin AustreidHans Petter Eikesdal
May 16, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Leo S Payne, Paul H Huang
May 18, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Hitomi KoizumiSeiji Yano
May 3, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho-Chul ShinGlen S Kwon
Aug 9, 2011·International Journal of Pharmaceutics·Usha KatragaddaChalet Tan
Jul 20, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Naruyuki KobayashiShinichiro Miyoshi
Aug 30, 2008·Experimental Cell Research·Sreenath V Sharma, Jeffrey Settleman
Jan 16, 2016·Leukemia Research and Treatment·Kalubai Vari Khajapeer, Rajasekaran Baskaran
Sep 20, 2011·Journal of Cellular Physiology·Tuanlao WangWanjin Hong
Oct 15, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tsuyoshi UenoShinichiro Miyoshi
Jan 31, 2015·American Journal of Respiratory Cell and Molecular Biology·Kyoung-Hee LeeChul-Gyu Yoo
Jun 4, 2015·Journal of Biomedical Science·Chi-Yuan ChenTzu-Chien V Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.